Vitamin D: The Complete 2026 Guide to Blood Levels, K2, and Dosing

Vitamin D is not really a vitamin — it is a secosteroid hormone synthesized in skin from 7-dehydrocholesterol under UVB radiation, hydroxylated in the liver to 25-hydroxyvitamin D (the storage form measured in blood), then converted in the kidney to 1,25-dihydroxyvitamin D (the active hormone). Deficiency is common in populations above 35 degrees latitude during winter, in darker-skinned individuals, in older adults, and in anyone who works indoors. The 2011 Endocrine Society Clinical Practice Guideline (Holick et al.) defined deficiency as 25(OH)D below 20 ng/mL (50 nmol/L) and insufficiency as 20–29 ng/mL, with the recommended target for at-risk populations at 30–50 ng/mL. Some researchers argue for 40–60 ng/mL; the large VITAL trial (Manson et al. 2019 NEJM) tempered enthusiasm for routine high-dose supplementation in vitamin-D-replete adults.

This guide synthesizes the 25(OH)D target debate, dosing by body weight and latitude, D3 vs D2 evidence, the K2 co-factor question, toxicity thresholds, and practical testing cadence.

How Vitamin D Works

Skin synthesis peaks when UV index exceeds 3, which outside the tropics means midday sun in summer only. Food sources (fatty fish, egg yolks, fortified dairy) contribute modestly. Once in circulation, 25(OH)D binds to vitamin D binding protein and has a half-life of approximately three weeks, making it the standard biomarker. The active 1,25(OH)2D hormone has a half-life of hours and is tightly regulated — testing it rarely helps.

D3 vs D2

Cholecalciferol (D3, from lanolin or lichen) and ergocalciferol (D2, from fungi) both raise 25(OH)D, but D3 is more potent and longer-lasting at equivalent doses. The Tripkovic et al. 2012 American Journal of Clinical Nutrition meta-analysis found D3 increased serum 25(OH)D roughly 1.7-fold more than D2. Most clinicians recommend D3 unless a vegan lichen-free source is required.

Target 25(OH)D Levels

25(OH)D level (ng/mL)	25(OH)D (nmol/L)	Status	Typical D3 dose	Re-test
<12	<30	Severe deficiency	50,000 IU/week x 8 weeks, then 1500–2000 IU/day	3 months
12–19	30–49	Deficiency	2000–4000 IU/day	3 months
20–29	50–74	Insufficiency (per Endocrine Society)	1500–2000 IU/day	3–6 months
30–50	75–125	Sufficient (target range)	1000–2000 IU/day maintenance	Annually
50–80	125–200	High-normal	Reduce to 800–1000 IU/day	6 months
>100	>250	Potentially toxic	Stop supplementation, re-test	1–3 months

The Institute of Medicine (2011) set a lower sufficient threshold (20 ng/mL) based on bone health endpoints for the general population. The Endocrine Society's 30 ng/mL target focuses on people at risk for deficiency. Both documents agree on the toxicity threshold (>150 ng/mL).

Dosing Strategy

By Body Weight

Ekwaru et al. 2014 PLOS One in a Canadian community-health cohort showed that obese adults require 2–3x the dose of normal-weight peers to reach the same serum level. A practical rule is 70–80 IU per kg body weight per day to maintain 30–50 ng/mL in most adults, adjusting on follow-up testing.

By Latitude and Season

North of roughly 35 degrees latitude (Atlanta, Tokyo, Casablanca), cutaneous synthesis effectively halts from October to March. Even tropical-dwelling individuals who work indoors often test deficient. A year-round 1000–2000 IU maintenance dose is reasonable for most adults, increased in winter or for higher baseline need.

Bolus vs Daily

Daily dosing is preferred. Large monthly or annual bolus doses (100,000+ IU) have been associated with increased fall and fracture risk in some trials (Sanders et al. 2010 JAMA; Bischoff-Ferrari et al. 2016 JAMA Internal Medicine). Small daily doses better mimic physiology.

The K2 Co-Factor Question

Vitamin K2 activates matrix Gla protein (MGP) and osteocalcin — proteins that direct calcium into bone and away from vascular walls. Schurgers et al. have published extensively on MK-7 (menaquinone-7) as the longest-circulating form. The Rotterdam Study (Geleijnse et al. 2004 Journal of Nutrition) associated higher K2 intake with lower aortic calcification. However, no large trial has proven that co-supplementing K2 with D3 prevents vascular calcification in humans.

MK-4 (short half-life, requires multiple daily doses) vs MK-7 (half-life 72 hours, once-daily dosing): MK-7 is the practical choice for supplementation, typically 90–180 mcg/day alongside D3.

Caveat: K2 is contraindicated for anyone on warfarin. Direct oral anticoagulants (apixaban, rivaroxaban) do not interact.

Calcium Balance

High-dose vitamin D increases intestinal calcium absorption. In the Women's Health Initiative and smaller trials, combined high-dose D plus calcium supplementation modestly raised kidney-stone risk (Jackson et al. 2006 NEJM). Most adults meeting calcium needs from diet do not need calcium supplements alongside D3. Those relying heavily on supplements should split doses and keep total elemental calcium below 1200 mg/day.

Toxicity Thresholds

Acute vitamin D toxicity (hypercalcemia) is rare but real. Case reports document toxicity from manufacturing errors, mis-dosed prescriptions, and chronic intake above 50,000 IU/day for months (Holick et al. 2011 J Clin Endocrinol Metab). The IOM set the Tolerable Upper Intake Level at 4000 IU/day for adults — a conservative threshold, with no documented toxicity below 10,000 IU/day in trials.

Symptoms: hypercalcemia (fatigue, confusion, polyuria, constipation), soft-tissue calcification. Stop supplementation and test 25(OH)D and calcium if suspected.

The VITAL Trial: What It Actually Showed

VITAL (Manson et al. 2019 NEJM) randomized 25,871 U.S. adults to 2000 IU D3/day vs placebo for 5.3 years. Primary outcomes — cancer and cardiovascular events — were not reduced. Subsequent sub-analyses found modest reductions in cancer mortality, advanced cancer incidence (Chandler et al. 2020 JAMA Network Open), and autoimmune disease incidence (Hahn et al. 2022 BMJ, with omega-3 co-supplementation).

Interpretation: in a population with median baseline 25(OH)D around 31 ng/mL (already sufficient), additional D3 offered limited benefit for primary cancer/CVD prevention but did reduce autoimmune disease onset by roughly 22% over five years. The argument for correcting documented deficiency remains strong; the argument for universal high-dose supplementation in replete adults is weaker.

Autoimmune Considerations

Vitamin D modulates T-regulatory cells and cytokine balance. Observational data link low 25(OH)D to multiple sclerosis risk (Munger et al. 2006 JAMA), and the VITAL autoimmune sub-analysis above strengthens causal inference. Target 40–60 ng/mL is commonly discussed in autoimmune contexts, though RCT evidence for this specific window remains indirect.

How Nutrola Helps

Nutrola tracks dietary vitamin D intake from over 100+ nutrients captured via photo AI and voice logging, and lets you log supplement doses alongside food. Seeing your combined intake over weeks — not just a single capsule — is how deficiency actually gets corrected. Nutrola's app starts at EUR 2.50/month with zero ads; Nutrola Daily Essentials (USD 49/month, lab tested, EU certified, 100% natural) includes D3 with K2 MK-7 in evidence-based doses. Nutrola holds a 4.9 rating across 1,340,080 reviews.

Practical Protocol

1. Test 25(OH)D at a known low-season time (late winter) and once in summer.
2. Supplement D3 (from lichen if vegan) at the dose matched to your starting level and weight.
3. Co-dose 90–180 mcg MK-7 if not on warfarin.
4. Re-test after 8–12 weeks; adjust.
5. Do not exceed 4000 IU/day without clinician oversight and follow-up testing.

This article is informational and not medical advice. Hypercalcemia, sarcoidosis, hyperparathyroidism, and some lymphomas affect vitamin D metabolism and require medical management. Always discuss supplementation with your clinician if you have a chronic condition or take prescription medications.

Frequently Asked Questions

What is the optimal 25(OH)D level?

The Endocrine Society recommends 30–50 ng/mL (75–125 nmol/L) for at-risk populations. Some clinicians advocate 40–60 ng/mL; trial evidence directly comparing these ranges is limited. Avoid exceeding 80 ng/mL without supervision.

Is vitamin D3 better than D2?

Yes, at equivalent doses. D3 raises serum 25(OH)D approximately 1.7 times more than D2 and persists longer (Tripkovic et al. 2012). Vegan D3 from lichen is widely available.

Do I need vitamin K2 with my D3?

K2 directs calcium into bone and away from arteries, and co-dosing is biologically plausible. Large RCT evidence for cardiovascular endpoints with combined D3+K2 is lacking, but adverse effects are minimal in non-anticoagulated adults. MK-7 at 90–180 mcg is the common dose.

Can I get enough vitamin D from sunlight?

Midday summer sun at latitudes below 35 degrees, with significant skin exposure for 15–30 minutes, produces 10,000+ IU. For most modern lifestyles — indoor work, sunscreen, winter, higher latitudes — dietary or supplemental vitamin D is needed most of the year.

What dose is safe long-term?

Up to 4000 IU/day is the established Tolerable Upper Intake Level for most adults. Higher doses (5000–10,000 IU) are often used clinically with monitoring but should not be self-prescribed without follow-up 25(OH)D testing.

Did the VITAL trial prove vitamin D doesn't work?

No. VITAL enrolled a largely vitamin-D-replete population and did not show primary cancer or CVD prevention at 2000 IU/day, but it did show reduced autoimmune disease incidence and several secondary cancer-related benefits. Correcting deficiency remains important.